Efthimiou, Petros <br/><br/>
Rituximab and lupus interstitial lung disease: friend or foe?  [electronic resource] 

 -  International journal of rheumatic diseases  Feb 2011 
 - e3-4 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1756-185X 
<br/><br/><label>Standard No.: </label>10.1111/j.1756-185X.2010.01592.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Antirheumatic Agents--therapeutic use<br/>Drug Therapy, Combination<br/>Dyspnea--drug therapy<br/>Glucocorticoids--therapeutic use<br/>Humans<br/>Hydroxychloroquine--therapeutic use<br/>Immunologic Factors--therapeutic use<br/>Lung Diseases, Interstitial--drug therapy<br/>Lupus Erythematosus, Systemic--complications<br/>Male<br/>Mycophenolic Acid--analogs & derivatives<br/>Prednisolone--therapeutic use<br/>Respiratory Function Tests<br/>Rituximab<br/>Sjogren's Syndrome--complications<br/>Treatment Outcome